Literature DB >> 24613932

Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.

Alexandru Hanganu1, Christophe Bedetti, Clotilde Degroot, Béatriz Mejia-Constain, Anne-Louise Lafontaine, Valérie Soland, Sylvain Chouinard, Marie-Andrée Bruneau, Samira Mellah, Sylvie Belleville, Oury Monchi.   

Abstract

Previous studies have shown greater atrophy in grey and white matter of various brain regions in patients with Parkinson's disease with mild cognitive impairment than in those without. These anatomical differences likely account for the distinct clinical profiles observed between those groups, but do not account for the evolution of regional brain degradation observed as the disease evolves. Although we have shown recently that cortical thinning correlates significantly more with disease duration in Parkinson's patients with mild cognitive impairment than in those without, to the best of our knowledge no study to date has explored this longitudinally. The present study investigated the longitudinal changes of the cortical and subcortical grey matter in patients with Parkinson's disease with and without mild cognitive impairment. Additionally, these two groups were compared with healthy controls. We found a higher rate of cortical thinning in the temporal, occipital, parietal and supplementary motor area, in patients with Parkinson's disease with mild cognitive impairment compared with both cognitively stable patients and healthy controls. On the other hand cognitively stable patients had only one lateral occipital and one fusiform cluster with increased rate of thinning compared with healthy individuals. Correlating the rate of change of cortical thickness with the results of Montreal Cognitive Assessment scores revealed significant thinning associated with cognitive decline in the group of all patients, in similar regions including temporal and medial occipital lobe. Finally, a significant decrease in the volume of the amygdala and nucleus accumbens was observed specifically in patients with Parkinson's disease with mild cognitive impairment. These results indicate that the early presence of mild cognitive impairment in patients with Parkinson's disease is associated with a faster rate of grey matter thinning in various cortical regions as well as a significant diminishment of limbic subcortical structures. This specific pattern of brain degradation associated with the early presence of mild cognitive impairment might serve as a marker of development toward dementia.

Entities:  

Keywords:  Parkinson’s disease; corticometry; longitudinal; magnetic resonance imaging; mild cognitive impairment

Mesh:

Year:  2014        PMID: 24613932     DOI: 10.1093/brain/awu036

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  71 in total

1.  The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions.

Authors:  Mechelle M Lewis; Guangwei Du; Eun-Young Lee; Zeinab Nasralah; Nicholas W Sterling; Lijun Zhang; Daymond Wagner; Lan Kong; Alexander I Tröster; Martin Styner; Paul J Eslinger; Richard B Mailman; Xuemei Huang
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

2.  Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.

Authors:  M Petrou; C Davatzikos; M Hsieh; B R Foerster; R L Albin; V Kotagal; M L Müller; R A Koeppe; W H Herman; K A Frey; N I Bohnen
Journal:  Acad Radiol       Date:  2016-02-10       Impact factor: 3.173

3.  Longitudinal white matter microstructural change in Parkinson's disease.

Authors:  Vincent Pozorski; Jennifer M Oh; Nagesh Adluru; Andrew P Merluzzi; Frances Theisen; Ozioma Okonkwo; Amy Barzgari; Stephanie Krislov; Jitka Sojkova; Barbara B Bendlin; Sterling C Johnson; Andrew L Alexander; Catherine L Gallagher
Journal:  Hum Brain Mapp       Date:  2018-06-27       Impact factor: 5.038

4.  We know now: Mavridis atrophy is associated with cognitive impairment in Parkinson disease.

Authors:  I N Mavridis
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-05       Impact factor: 3.825

Review 5.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

6.  Is nucleus accumbens atrophy correlated with cognitive symptoms of Parkinson's disease?

Authors:  Ioannis N Mavridis
Journal:  Brain       Date:  2014-07-16       Impact factor: 13.501

7.  Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

Authors:  Brit Mollenhauer; Johannes Zimmermann; Friederike Sixel-Döring; Niels K Focke; Tamara Wicke; Jens Ebentheuer; Martina Schaumburg; Elisabeth Lang; Ellen Trautmann; Henrik Zetterberg; Peggy Taylor; Tim Friede; Claudia Trenkwalder
Journal:  Neurology       Date:  2016-05-06       Impact factor: 9.910

8.  Genome-wide Analysis of RARβ Transcriptional Targets in Mouse Striatum Links Retinoic Acid Signaling with Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Anna Niewiadomska-Cimicka; Agnieszka Krzyżosiak; Tao Ye; Anna Podleśny-Drabiniok; Doulaye Dembélé; Pascal Dollé; Wojciech Krężel
Journal:  Mol Neurobiol       Date:  2016-07-12       Impact factor: 5.590

Review 9.  Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.

Authors:  Jing Yang; Roxana G Burciu; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

10.  A pilot study on the benefit of cognitive rehabilitation in Parkinson's disease.

Authors:  Natalia Adamski; Matthias Adler; Klaus Opwis; Iris-Katharina Penner
Journal:  Ther Adv Neurol Disord       Date:  2016-02-16       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.